Follow
Ariadna Grinyo Escuer
Ariadna Grinyo Escuer
PhD Candidate, Vall d'Hebron Institute of Oncology
Verified email at vhio.net
Title
Cited by
Cited by
Year
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
Z Ku, X Xie, E Davidson, X Ye, H Su, VD Menachery, Y Li, Z Yuan, ...
Nature communications 12 (1), 469, 2021
1462021
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
V Dussupt, RS Sankhala, GD Gromowski, G Donofrio, RA De La Barrera, ...
Nature medicine 26 (2), 228-235, 2020
682020
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection
AT Waickman, GD Gromowski, W Rutvisuttinunt, T Li, H Siegfried, K Victor, ...
EBioMedicine 54, 2020
262020
Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
F Chen, N Tzarum, X Lin, E Giang, R Velázquez-Moctezuma, ...
Immunity 54 (4), 781-796. e4, 2021
252021
An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
T Kotaki, T Kurosu, A Grinyo-Escuer, E Davidson, S Churrotin, ...
Scientific Reports 11 (1), 12987, 2021
182021
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
Z Ku, X Xie, E Davidson, X Ye, H Su, VD Menachery, Y Li, Z Yuan, ...
Nature communications 12, 2021
152021
Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications
JC Whitbeck, A Thomas, K Kadash-Edmondson, A Grinyo-Escuer, ...
PLoS neglected tropical diseases 14 (11), e0008730, 2020
92020
Proteo-genomic analysis identifies two major sites of vulnerability on Ebolavirus glycoprotein for neutralizing antibodies in convalescent human plasma
P Gilchuk, A Guthals, SR Bonissone, K Huang, BM Gunn, G Alter, ...
Frontiers in immunology 12, 706757, 2021
52021
An affinitymatured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency. Sci Rep. 2021; 11: 12987
T Kotaki, T Kurosu, A Grinyo-Escuer, E Davidson, S Churrotin, ...
5
A novel antigenic site spanning domains I and III of the Zika virus envelope glycoprotein is the target of strongly neutralizing human monoclonal antibodies
SD Graham, HA Tu, BD McElvany, NR Graham, A Grinyo, E Davidson, ...
Journal of Virology 95 (9), 10.1128/jvi. 02423-20, 2021
42021
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane
E Saphire, ZL Salie, Z Ke, P Halfmann, LE DeWald, S McArdle, A Grinyo, ...
2023
COMPREHENSIVE MUTAGENESIS OF DENGUE VIRUS ENVELOPE PROTEINS TO MAP ANTIBODY EPITOPES AND IDENTIFY RESIDES ESSENTIAL FOR FUNCTION
E Davidson, JT Sullivan, JM Pfaff, A Grinyo, ME Fouch, BJ Doranz
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 105 (5), 329-329, 2021
2021
COMPREHENSIVE MUTAGENESIS OF SARS-COV-2 S PROTEIN TO MAP ANTIBODY EPITOPES AND IDENTIFY RESIDES ESSENTIAL FOR FUNCTION
E Davidson, A Grinyo, ME Fouch, JK Williams, CN Selverian, Z An, ...
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 105 (5), 152-152, 2021
2021
CHARACTERIZING THE IMMUNE RESPONSE TO ZIKA VIRUS USING EPITOPE MAPPING, REPORTER VIRUS PARTICLES, AND ANTI-ZIKV ANTIBODIES
E Davidson, JC Whitbeck, A Thomas, JT Sullivan, A Grinyo, LJ Stafford, ...
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 105 (5), 191-191, 2021
2021
An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus within vivotherapeutic potency
T Kotaki, T Kurosu, A Grinyo, E Davidson, S Churrotin, T Okabayashi, ...
2020
The system can't perform the operation now. Try again later.
Articles 1–15